The Microbiological Spectrum in Acute Dacryocystitis

Dacryocystitis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00349297
• Other study ID #: R325/18/2003
• Status: Completed
• Phase: N/A
• First received: July 5, 2006
• Last updated: May 11, 2010
• Start date: November 2003
• Est. completion date: May 2008

Study information

• Verified date: May 2010
• Source: Singapore National Eye Centre
• Contact: n/a
• Is FDA regulated: No
• Health authority: Singapore: Health Sciences Authority
• Study type: Observational

Clinical Trial Summary

Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy.

The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms.

The study also aims to correlate the microbiological findings to the severity of clinical manifestations and evaluate the effectiveness of our current practice of aspiration and empiric systemic antibiotic therapy in treating patients with acute dacryocystitis and hence review whether there is a need to alter current management strategy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: May 2008
• Est. primary completion date: May 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

INCLUSION CRITERIA:

• Painful localised fluctuant induration just inferior to the medial canthal tendon of less than 2 weeks duration.

EXCLUSION CRITERIA:

• Non-fluctuant lacrimal sac swelling

• Uncooperative patient

• Unwilling Patient

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Dacryocystitis

Locations

Country	Name	City	State
Singapore	Singapore National Eye Centre	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Singapore National Eye Centre

Country where clinical trial is conducted

Singapore,